The slip
PARKINSON RECEIPTno. 4141
20 Oct 2026, 10:49 UTCdopamine neurons, braak
predictionHGS in dopamine neurons tracks Braak Lewy-body stage
registeredb397d416bb972557
discovery+0.29 p=0.442 n=9
replication-0.63 p=0.068 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.29, p 0.442)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT75e4fe4ee31339d82d779e2a…
follows 9b4ea0df806a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4141: HGS in dopamine neurons, braak
- power
- full sample -0.28 (p 0.254, n 18), 95% CI -0.66 to +0.21. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.29 (p 0.243, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.28 (p 0.261, n 18). could be the mix.
- skeptic
- leave-one-out range -0.47 to -0.18, sign flips 0; without severely affected donors -0.28 (p 0.254, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.73 (p 6.2e-4, n 18) vs -0.28 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for HGS in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up HGS · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.73 p 0.0100 (needs p < 4.7e-4)